Regulatory Roundup

Regulatory Roundup November 17, 2026

AWG Regulatory Roundup — November 17, 2026

Subscribe here!

FDA Proposes Rule to Allow NAC in Dietary Supplements

FDA has proposed a rule that would allow N-acetyl-L-cysteine (NAC) to be marketed as a dietary supplement, notwithstanding its prior approval as a drug. The proposed rule, titled “Dietary Ingredients Not Excluded from the Dietary Supplement Definition,” provides a mechanism for permitting ingredients that would otherwise be excluded from the definition of “dietary supplement” under Section 201(ff)(3)(B) of the FD&C Act to be marketed in or as dietary supplements. The proposed rule would also address the corresponding prohibition under Section 301(ll) of the FD&C Act on adding an approved drug to food. NAC would be the first ingredient listed under the new regulation.

FDA previously determined that NAC was excluded from the dietary supplement definition because it was approved as a new drug before being marketed as a dietary supplement or conventional food. In 2022, FDA issued guidance announcing that it would exercise enforcement discretion with respect to certain NAC-containing products labeled as dietary supplements. Notably, this marks the first time FDA has exercised its authority under Section 201(ff)(3)(B) to issue a regulation providing an exception to the drug preclusion provision, and paves the way for FDA to use this regulatory mechanism to address other ingredients subject to drug preclusion. Comments on the proposed rule must be submitted within 60 days of its publication in the Federal Register.

Back to Top

FDA Revokes Certain Color Additive Authorizations

On November 9, 2026, FDA announced it is revoking the authorizations of certain substances used as color additives or in the production of color additives in response to separate color additive petitions. First, FDA is revoking the authorization for the use of methylene chloride as a diluent in inks for marking fruit and vegetables, citing the Delaney Clause. Additionally, FDA is revoking authorizations for methylene chloride, ethylene dichloride, and trichloroethylene in the manufacture of certain color additives after determining that industry has abandoned those uses. The revocations take effect January 11, 2027.

Back to Top

Infant Formula Standards Under Review as FDA Begins Rulemaking

On November 2, 2026, FDA issued a Notice of Proposed Rulemaking (NPRM) on infant formula nutrient requirements, reflecting the agency’s findings from the first phase of its three-phase review of the nutrients required in infant formula marketed in the U.S. In Phase 1, FDA evaluated the minimum and/or maximum levels of iodine, manganese, selenium, sodium, potassium, chloride, vitamin A, and vitamin D and, based on its review, proposes amending the minimum and/or maximum levels of iodine, manganese, vitamin A, and vitamin D. FDA also proposes reaffirming the existing requirements for sodium, potassium, selenium, and chloride, and changing the units of measure for vitamin A and vitamin D and limiting the permitted forms of vitamin A.

The subsequent two phases, which FDA states are underway, will assess the remaining required nutrients, potential new nutrient requirements, and carbohydrate sources. Each phase will be issued as a separate NPRM, but FDA intends to consolidate all changes to infant formula nutrient requirements into a single comprehensive final rule. If finalized, the rulemaking would require manufacturers to update infant formula labeling to align with the proposed nutrient changes. Industry may submit comments on the proposed rule until March 2, 2027.

Back to Top

FDA and NIH to Host Workshop Spotlighting Alternative Safety Testing Methods

FDA’s Human Foods Program (HFP) and NIH’s Office of Research Innovation, Validation, and Application (ORIVA) are hosting a workshop on March 10-12, 2027, focused on advancing New Approach Methods (NAMs) for food chemical and dietary supplement safety assessments. The workshop will bring together regulators, researchers, and industry stakeholders to advance the development, qualification, and regulatory integration of NAMs.

Back to Top

Updates to Food Allergen Labeling FAQs

FDA has updated its Frequently Asked Questions webpage on the Food Allergen Labeling Guidance for Industry. The update adds two new “Questions and Answers” addressing cross-contact controls for milk and egg allergens on shared equipment, including FDA’s position that separate cross-contact controls are not expected for products made with different types of milk or eggs, provided the products do not differ with respect to other major food allergens. The update also reflects FDA’s current thinking on existing questions and clarifies allergen declaration requirements for milk from different animal sources and eggs from different bird species.

Back to Top

FDA Issues Draft Guidance to Help Navigate U.S.-Origin Claims on Seafood Products

On October 27, 2026, FDA announced the availability of a draft guidance providing examples of U.S.-origin seafood product labeling claims the agency would consider truthful and not misleading. The guidance addresses both single-ingredient seafood and the seafood ingredients of multi-ingredient foods, but it does not address origin claims from states, territories, or localities. FDA provides examples of claims such as “U.S.-Caught,” “U.S. Farm-Raised,” “USA Seafood,” or “Made with U.S. Seafood,” as well as use of U.S.-origin imagery such as the American flag. When only certain aspects of a product are connected to the U.S., FDA recommends accompanying disclosures clarifying which activities (e.g., harvesting or processing) occurred in the U.S. Industry may submit comments on the draft guidance until December 28, 2026.

Back to Top

Toast Sued Over Fees and Subscriptions

On October 29, 2026, the FTC announced that, along with several State Attorneys General, it filed a lawsuit against Toast Inc. and affiliated entities over alleged deceptive practices related to subscription services and financing products. According to the complaint, Toast enrolled customers in subscription add-on services without consent and failed to provide simple cancellation mechanisms, while imposing high termination fees. The complaint also alleges that Toast failed to disclose required fees and charged customers for unauthorized add-ons.

Back to Top

FTC Probes Personalized Pricing Practices

On October 28, 2026, the FTC issued orders to certain airlines, ride-sharing and food-delivery platforms, and large retailers seeking information about personalized pricing practices. Specifically, the agency is investigating whether prices for flights, rides, deliveries, and other products or services vary among consumers based on factors such as loyalty program participation or the use of personal data by artificial intelligence-driven pricing systems. The inquiry reflects the FTC’s continued focus on how companies use consumer data and AI to set prices, particularly when consumers may be charged different amounts for the same products or services.

Back to Top

IN DEPTH: A Lesson in Trademark Licensing

Can a U.S. licensee claim ownership of a foreign brand’s trademark after the licensing relationship falls apart? That question is playing out right now in federal court in New York, and it offers a simple but important message for brand owners and licensees expanding across borders.

Shenzhen Molly Tea expanded its Chinese jasmine tea brand into the US through New York shop operators. When a dispute arose over licensing terms, the relationship fractured. The New York shops claimed that the Chinese parent company lacked US common law rights to the “Molly Tea” name and could not stop them from using it.

In court, the New York licensees argued that because they built the local market presence, they owned the domestic rights in the trademark. But under basic licensing principles, a licensee’s use of a trademark inures to the benefit of the licensor. That means as a licensee, you don’t own the rights and goodwill being created by your use of the licensed trademark.

A key takeaway for brand owners and founders is that trademark licensing requires carefully drafted territorial and ownership clauses (for the sake of both parties in the deal). Operating a foreign brand (or any brand) as a licensee in the U.S. without explicit language about whether domestic goodwill inures to the licensor or the licensee invites disaster if the business relationship sours. Local presence does not automatically equal brand ownership.

If you have questions about trademark licensing, ownership issues, or any trademark matters, we would love to hear from you.

Back to Top